Covaxin booster shot enhances efficacy against Delta, Omicron variants of COVID-19: Study
Wednesday, July 6, 2022
  • Circulation
  • Advertise
  • About Us
  • Contact Us
Organiser
  • ‌
  • Bharat
  • World
  • Editorial
  • Analysis
  • Opinion
  • Defence
  • Sports
  • Business
  • More
    • RSS in News
    • Special Report
    • Culture
    • Sci & Tech
    • Entertainment
    • Education
    • Books
    • Interviews
    • Travel
    • Health
    • Obituary
SUBSCRIBE
No Result
View All Result
Organiser
  • ‌
  • Bharat
  • World
  • Editorial
  • Analysis
  • Opinion
  • Defence
  • Sports
  • Business
  • More
    • RSS in News
    • Special Report
    • Culture
    • Sci & Tech
    • Entertainment
    • Education
    • Books
    • Interviews
    • Travel
    • Health
    • Obituary
No Result
View All Result
Organiser
No Result
View All Result
  • Home
  • Bharat
  • World
  • Editorial
  • Opinion
  • Analysis
  • Culture
  • Defence
  • RSS in News
  • Subscribe
Home Bharat

Covaxin booster shot enhances efficacy against Delta, Omicron variants of COVID-19: Study

The study by 'bioRxiv', an open-access preprint repository for the biological sciences shows that Covaxin booster dose would enhance the vaccine effectiveness against the Delta variant infection and give protection against two Omicron variants of COVID-19.

WEB DESK by WEB DESK
Jun 15, 2022, 02:07 pm IST
in Bharat
Share on FacebookShare on TwitterTelegramEmail

New Delhi [India], June 15 (ANI): A study showed that administration of Covaxin booster dose would enhance the vaccine effectiveness against the Delta variant infection and give protection against two Omicron variants of COVID-19.

The study by ‘bioRxiv’, an open-access preprint repository for the biological sciences, shared on Tuesday that its study shows that administration of Covaxin booster dose will enhance the vaccine effectiveness against the Delta variant infection and give protection against the Omicron variants BA.1.1 and BA.2.

The study analysed about the immunity acquired after natural infection or vaccinations against SARS-CoV-2. Vaccine effectiveness also varies with the variant of infection, the study said.

Download Organiser App

The study compared the protective efficacy of Covaxin following the second and third dose immunisations against the Delta variant and also studied the efficacy of Covaxin against Omicron variants in a ‘Syrian hamster model’.

“The antibody response, clinical observations, viral load reduction and lung disease severity after virus challenge were studied. The protective response in terms of the reduction in lung viral load and lung lesions were observed in both the second dose as well as third doses of Covaxin immunised group when compared to placebo group following the Delta variant challenge,” the study said.

The study further reads, “In spite of the comparable neutralising antibody response against the homologous vaccine strain in both the second dose and third dose immunised groups, considerable reduction in the lung disease severity was observed in the third dose immunised group post-Delta variant challenge indicating the involvement of cell-mediated immune response also in protection.”

“In the vaccine efficacy study against the Omicron variants i.e., BA.1 and BA.2, lesser virus shedding, lung viral load and lung disease severity were observed in the immunised groups in comparison to the placebo groups. The present study shows that administration of COVAXIN booster dose will enhance the vaccine effectiveness against the Delta variant infection and give protection against the Omicron variants BA.1.1 and BA.2,” it concluded.

Phase 3 results of the Covaxin, developed by the Indian Council of Medical Research (ICMR) in partnership with Bharat Biotech International Limited (BBIL), have shown an interim vaccine efficacy of 81 per cent in preventing Covid-19.

Covaxin is the first COVID-19 vaccine that has been developed completely in India. On January 16, 2021, India commenced its nationwide vaccination drive. (ANI)

Topics: COVID-19COVAXINBharat BiotechCovidOmicron variantDelta Variant
ShareTweetSendShareSend
Previous News

New ’10 lakh’ job announcement – a game-changer by PM Narendra Modi

Next News

Iranian media spreads fake news to fuel kafirophobia in India

Related News

All Above 18 Eligible for Vaccination From May 1, Announces Centre

India’s COVID vaccination coverage exceeds 197.95 cr

Yoga continues to intensify action to increase physical activity and enhance mental health: WHO Regional Director

Yoga continues to intensify action to increase physical activity and enhance mental health: WHO Regional Director

Clinical phase III trials of the Bharat Biotech’s COVID-19 nasal vaccine completed

Clinical phase III trials of the Bharat Biotech’s COVID-19 nasal vaccine completed

Japan recognises India’s COVAXIN to facilitate travel between both countries

Covaxin safe for children aged 2-18 years, says Bharat Biotech

China reports 360 new COVID-19 cases, food shortage hurting Shanghai residents

Beijing under threat of severe COVID-19 outbreak

India’s daily cases fall below 3,000-mark, logs in 2,568 new COVID-19 infections

India logs 6,594 new COVID cases, 18 pc fewer than the previous day

Comments

The comments posted here/below/in the given space are not on behalf of Organiser. The person posting the comment will be in sole ownership of its responsibility. According to the central government's IT rules, obscene or offensive statement made against a person, religion, community or nation is a punishable offense, and legal action would be taken against people who indulge in such activities.

Latest News

Himachal Pradesh: Dalai Lama makes first public appearance after two years in Dharamshala

Dalai Lama:  Spiritual leader of Buddhism

US Abortion Row: What USA can learn from India

US Abortion Row: What USA can learn from India

PM Modi to inaugurate Akhil Bharatiya Shiksha Samagam on implementation of NEP in Varanasi

PM Modi to inaugurate Akhil Bharatiya Shiksha Samagam on implementation of NEP in Varanasi

Gujarat Riots: How Hindi film industry pushed anti-Hindu narratives

Gujarat Riots: How Hindi film industry pushed anti-Hindu narratives

Ajmer Dargah cleric Salman Chishti arrested for incendiary statement against Nupur Sharma

Ajmer Dargah cleric Salman Chishti arrested for incendiary statement against Nupur Sharma

Maha Vikas Aghadi (MVA)  Experiment was bound to fail 

Maha Vikas Aghadi (MVA)  Experiment was bound to fail 

‘Vasudeva Kutumbakam’ – Naga BJP leader’s missive to Christians in Chennai

‘Vasudeva Kutumbakam’ – Naga BJP leader’s missive to Christians in Chennai

Report : More than meets the Eye

Challenges before the Dalai Lama

FIRs filed in Uttar Pradesh, Delhi against ‘Kaali’ filmmaker

‘Kaali’ poster row: Canadian museum regrets offence caused to Hindu community

Eknath Shinde: Man who stole the March

BJP had more numbers, supported us for our Hindutva position, development agenda: CM Eknath Shinde

  • Privacy
  • Terms
  • Cookie Policy
  • Refund and Cancellation
  • Delivery and Shipping Policy

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies

No Result
View All Result
  • Home
  • Bharat
  • World
  • Editorial
  • Analysis
  • Opinion
  • Defence
  • Culture
  • Sports
  • Business
  • RSS in News
  • Special Report
  • Sci & Tech
  • Entertainment
  • Education
  • Books
  • Interviews
  • Travel
  • Health
  • Obituary
  • Subscribe
  • Advertise
  • Circulation
  • About Us
  • Contact Us
  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Refund and Cancellation

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies